Table 3 ICU admission (%) of all SARS-Cov2 positive cases (18 + Ages) after Jan 30th.
From: Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain
Vaccine type | Total rate (ICU) | > 50 rate (ICU) | < 50 rate (ICU) | ||||||
|---|---|---|---|---|---|---|---|---|---|
Rate (total) | LCL UCL | OR | Rate (total) | LCL UCL | OR | Rate (total) | LCL UCL | OR | |
Unvaccinated | 2.02 (1232) | 1.87 2.17 | NA | 7.55 (792) | 6.90 8.23 | NA | 0.87 (440) | 0.77 (0.98) | NA |
Sinopharm | 0.57 (138) | 0.45 1.70 | 3.6 | 1.7 (114) | 1.32 2.14 | 4.72 | 0.14 (24) | 0.08 0.22 | 6.4 |
Sputnik V | 0 (0) | 0.00 0.11 | inf | 0 (0) | 0.00 1.03 | inf | 0 (0) | 0.00 0.13 | inf |
Pfizer-BioNtech | 0.05 (1) | 0.00 0.32 | 41.3 | 0.23 (1) | 0.01 1.47 | 35.3 | 0 (0) | 0.00 0.25 | inf |
Covishield | 0.1 (3) | 0.02 0.34 | 20.3 | 0.17 (1) | 0.01 1.11 | 46.7 | 0.08 (2) | 0.01 0.35 | 10.4 |
